SERPINF1 and Parkinson disease: Such properties were tested and demonstrated by Falk and colleagues [40] who, by comparing PEDF with other PD therapeutic molecules (as GDNF), showed that PEDF has advantages in the ease of delivery and amelioration of functional outcomes.